Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
SDi Predicts a Surge in Demand in the Water Testing Market for Analytical Instrumentation
In the past few years, select governments around the world have emphasized the societal importance of clean water by passing legislation for safer drinking water and combating climate change and other environmental hazards. Water testing is one of the many avenues that scientists and others utilize to monitor water safety and pollution. Laboratories could not […]
Syncell: Advancing Spatial Proteomics
Founded in 2020, Syncell launched its first products at the beginning of last year. The Microscoop Mint and Synlight photolabeling kit and Synpull protein extraction reagents together offer a subcellular solution for spatial proteomics by utilizing laser nano-pulldown (LNP). In 2024, the company closed a $15 million Series A funding, led by Taiwania Capital. The […]
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
Tariff announcements and changes in the academic and government funding landscape in the US are the latest challenges facing the laboratory tools industry. But, according to Strategic Directions International’s (SDi’s) 2025 “Global Assessment Report,” despite these challenges and others, the compound annual growth rate (CAGR) for laboratory instruments will increase in coming years. Five-Year Market […]
NIH Disruptions and Lab Tool Companies: Stocks React
One likely effect of the new US government’s recent actions to disrupt NIH grant funding to US universities has been a hit to stock prices of suppliers of life science instrumentation for university R&D. The Trump Administration’s actions include restrictions and terminations of grants, as well as delays or cancellations of grant review meetings and […]
Federal R&D Obligations for the NIH Decline in FY24
The recent plan by the Trump Administration to cap indirect costs for NIH academic research, which has been put on hold by a federal judge, as well as cuts to several other agencies that are major funders of R&D, has put the spotlight on federal R&D spending. This month, the National Science Foundation’s (NSF’s) National […]